All stories
Jump to date
Wednesday, July 22 · 2 stories
- Industry
Commentary Argues Behavioral Health Needs Better Prescribing Infrastructure Over Deprescribing Focus
A MedCity News commentary argues that the behavioral health policy conversation should shift from deprescribing initiatives to building clinical infrastructure for consistent, high-quality care. The piece challenges the current policy emphasis on reducing prescriptions and instead advocates for systematic improvements in prescribing practices. The commentary does not announce specific policy changes or requirements but contributes to ongoing discussions about behavioral health quality in managed care settings.
Tuesday, July 21 · 3 stories
- Industry
Novo Nordisk Sues Eli Lilly Over Obesity Drug Advertising Claims
Novo Nordisk has filed a lawsuit against Eli Lilly alleging misleading advertising of Lilly's GLP-1 obesity medications. The suit, which follows a cease-and-desist demand, claims Lilly is using deceptive advertisements to portray its products as broadly superior to Novo's competing medicines. Lilly has responded that its marketing campaign is truthful. The legal action comes as both manufacturers compete intensively in the rapidly growing obesity treatment market.
- Industry
Stanford Expert Discusses Evolving AI Regulation in Health Care Delivery
Dr. Michelle Mello of Stanford's Healthcare Ethical Assessment Lab for AI discussed regulatory frameworks for artificial intelligence deployment in clinical settings during an interview. The conversation addressed accountability structures, oversight mechanisms, and liability questions as AI tools increasingly enter medical practice. While the discussion covers broader health care AI governance, specific Medicaid managed care implications were not detailed. The podcast explores ongoing policy development rather than reporting finalized regulatory action.
- Industry
Clinic and Physician Practice Bankruptcies Spike in 2026
Healthcare provider bankruptcies have increased sharply in 2026, driven in part by Medicaid payment cuts, according to a Gibbins Advisors report. The trend affects clinics and physician practices across the sector. The financial pressures are ongoing, with no specific effective date noted. For Medicaid managed care organizations, provider network stability is at risk as financial strain forces practice closures, potentially creating access gaps and requiring network adequacy monitoring.
Monday, July 20 · 2 stories
- Industry
KFF Poll Finds Public Uncertainty Dominates Vaccine Myth Responses
A new KFF tracking poll on health information and trust reveals that uncertainty over common vaccine myths is more prevalent among the public than firm belief or denial. The analysis categorizes respondents into consistent myth believers, consistent myth deniers, and a "mixed middle" group that expresses uncertainty. The poll provides insight into public attitudes that may affect vaccine uptake and health plan member engagement strategies. Results suggest health plans may need tailored communication approaches for populations with varying levels of vaccine hesitancy and misinformation exposure.
- Industry
Clover Health Discloses Data Breach in Securities Filing
Clover Health reported a data breach in a securities filing last week. The Medicare Advantage insurer has not yet determined what type of data was exposed or how many individuals were affected. The company is investigating the incident and has not provided a timeline for breach notification or remediation. Clover operates Medicare Advantage plans in multiple states and serves tens of thousands of enrollees.
Friday, July 17 · 7 stories
- Industry
UnitedHealth Raises 2026 Guidance on Q2 Profit Growth
UnitedHealth reported $5.5 billion in profit for Q2 2026, driven by earnings recovery in its insurance and value-based care delivery operations. The company raised its full-year 2026 financial guidance based on improved cost controls across its business segments. UnitedHealth's insurance arm, which includes Medicaid managed care operations, showed stronger performance alongside growth in its Optum value-based care division. The earnings beat reflects operational improvements following cost control measures implemented across the enterprise.
- Industry
Home Health Providers Pursue Joint Ventures During CMS Enrollment Moratorium
CMS imposed a six-month moratorium on new Medicare home health enrollments, limiting traditional expansion paths for providers. Industry operators report that growth-minded agencies are pursuing organic growth, mergers and acquisitions, and joint ventures to scale operations despite enrollment restrictions. The moratorium affects provider capacity to enter new markets through new enrollments but does not prevent changes of ownership or partnerships with existing enrolled agencies. Providers are adapting expansion strategies to work within the temporary enrollment freeze.
- Industry
ACA Marketplace Premiums Rise in 2027 Rate Filings
Health insurers have submitted 2027 rate filings to state regulators for individual market plans sold through ACA Marketplaces, showing premium increases. The filings detail insurer expectations and the factors driving rate changes for the coming plan year. Rate filings occur annually each spring and summer as part of the regulatory approval process. This development affects individual market plans, which operate separately from Medicaid managed care but may inform broader health plan pricing trends and cost drivers affecting the commercial insurance market.
- Industry
Commonwealth Fund Research Examines Private Equity Ownership in Four-State Hospital Analysis
The Commonwealth Fund is supporting new research analyzing private equity ownership patterns in hospitals and provider groups across four states. The research examines how private equity investments are affecting healthcare delivery organizations. The analysis provides state-level detail on ownership structures and operational changes. For Medicaid managed care organizations, private equity ownership of network providers can affect network stability, care continuity, service availability, and provider contracting dynamics.
- Industry
TrumpRx Discount Website Covers Limited Share of Brand-Name Drugs After Six Months
The TrumpRx administration-backed prescription drug discount website has been operational for nearly six months but covers only a fraction of brand-name medications. The platform's limited formulary raises questions about its practical utility for consumers seeking prescription cost relief. The scope of coverage and actual impact on out-of-pocket costs remains unclear. For Medicaid managed care organizations, this development is relevant only if it affects member cost-sharing, supplemental benefit design, or pharmacy network strategies.
- Industry
Insurers to Pay $759 Million in MLR Rebates for 2024 Performance
Health insurers will pay an estimated $759.2 million in Medical Loss Ratio rebates in 2026 based on 2024 performance, according to KFF analysis of preliminary data filed with state regulators. The rebates go to individuals and employers in fully-insured plans where insurers failed to meet minimum MLR thresholds—80% for individual and small group markets, 85% for large group plans. This year's rebate total is lower than most prior years. Payments typically reach consumers by September 30, 2026.
- Industry
Peterson Health Technology Institute Examines AI Deployment in Prior Authorization and Medical Billing
The Peterson Health Technology Institute is evaluating how providers and payers are deploying artificial intelligence in administrative functions including prior authorization, medical coding, and billing. Providers are using AI tools to optimize revenue capture and documentation, while insurers deploy similar technology for claims review and utilization management. PHTI's executive director Caroline Pearson notes the central question is whether these technologies reduce total healthcare spending or simply accelerate existing reimbursement disputes. The institute previously found that digital diabetes management tools did not lower overall cost of care.
Thursday, July 16 · 3 stories
- Industry
KFF Analysis Examines Why Drug Prices Dominate Policy Debate Over Hospital Costs
KFF's Larry Levitt published a JAMA Health Forum post identifying four reasons why high drug prices receive more policy attention than hospital prices, despite hospitals accounting for 40% of national health spending growth from 2022 to 2024. The analysis explores barriers to hospital price restraint and potential policy interventions. The post provides context for understanding the political economy of health care cost containment efforts. No immediate policy changes are announced.
- Industry
Rural Hospitals Face Unique Payer Contracting Pressures from Geography and Payer Mix
Rural hospitals are confronting distinct challenges in managed care contracting driven by limited scale, geographic isolation, and constrained payer mix. These providers must navigate tighter margins than their urban counterparts while negotiating contracts that often fail to account for rural delivery realities. The article examines how rural facilities can strengthen their negotiating position despite structural disadvantages. These dynamics affect Medicaid managed care organizations with rural network obligations and rural health plan adequacy requirements.
- Industry
HCA Cuts 2026 Earnings Forecast After $400M Loss on ACA Coverage Drops
HCA Healthcare reduced its 2026 earnings forecast after losing $400 million in the second quarter due to payer mix changes, primarily from patients dropping Affordable Care Act marketplace coverage. The coverage losses exceeded both company and investor expectations. The development affects the second quarter of 2026, with the company announcing revised earnings guidance in July 2026. For Medicaid managed care organizations, this signals potential market instability and coverage churn that could affect member attribution, provider network partnerships, and redetermination processes if consumers losing marketplace coverage seek Medicaid eligibility.
Wednesday, July 15 · 6 stories
- Industry
Children's Hospitals Face 16 Active Pediatric Drug Shortages Including Six IV Products
Pediatric drugs represent the therapeutic category most affected by active drug shortages, with 16 ongoing shortages including six involving IV fluids and additives. Children's hospitals face unique challenges managing these shortages compared to adult health systems due to weight-based dosing, limited alternative formulations, and smaller patient volumes that reduce purchasing leverage. The article examines operational strategies pediatric hospitals use to manage supply disruptions, though specific policy interventions or effective dates are not detailed.
- Industry
720 Rural Hospitals at Risk of Closure as Surgical Access Gaps Widen
A Center for Healthcare Quality and Payment Reform report finds that roughly one-third of rural hospitals — 720 facilities — face closure risk, raising questions about surgical access in underserved areas. As rural hospitals retreat from operating room services, the analysis highlights growing surgical care deserts. The report does not specify a timeline for closures but underscores ongoing financial instability in rural provider markets. For Medicaid managed care organizations with rural network obligations, this trend signals potential network adequacy challenges and increased need for alternative surgical access strategies.
- Industry
Elevance Health Plans Further Medicaid Portfolio Exit Amid High Costs
Elevance Health, the nation's second-largest health insurer, announced plans to reduce its Medicaid managed care footprint over the next year as medical costs remain elevated. The exit comes as states prepare to implement Medicaid work requirements. Elevance operates Medicaid plans in multiple states under its Anthem and Wellpoint brands. The decision reflects ongoing profitability challenges in Medicaid managed care following the end of pandemic-era continuous enrollment provisions.
- Industry
Providers Report Rising Denial Rates Despite Revenue Cycle Automation Gains
Health systems have invested heavily in revenue cycle automation over two decades, with the 2025 CAQH Index estimating $258 billion in avoided administrative costs in 2024. Despite these efficiency gains, denial rates continue to climb, with 41 percent of providers now reporting at least one in ten claims denied—a figure that has increased annually. The trend suggests automation alone has not resolved underlying issues driving claim denials, including prior authorization requirements, documentation standards, and payer policies.